Carrot has announced new partnerships with ŌURA, the smart-ring company, and Dexcom, a global leader in glucose biosensing, to expand the support available to members navigating fertility, family-building, and hormonal health. The collaboration connects Carrot’s clinical expertise with advanced biometric information from the Oura Ring and Stelo by Dexcom, the first FDA-cleared glucose biosensor available over the counter in the United States.
The partnership centres on Carrot’s metabolic-fertility programme, Sprints, and will give members access to integrated biometric data designed to support better decision-making throughout fertility and conception journeys. Through the new arrangement, Carrot members enrolled in Sprints will be able to monitor a wide range of health indicators, including activity levels, sleep, stress, cardiovascular metrics, and women’s health data collected via the Oura Ring. Glucose readings will be provided through a new integration with Stelo.
According to Carrot, combining wearable technology with specialised clinical guidance will help members understand key metabolic patterns associated with fertility challenges. The Sprints programme aims to address obstacles linked to obesity, blood-sugar dysregulation, sperm damage, and other common features of metabolic disorder.
Hilary Bartlett, Chief Product Officer at Carrot, said, “A new wave of consumer health innovation is shining a spotlight on women’s health and hormonal health. Putting data in the hands of our members is an important first step, but it needs to be paired with actionable support from experts to improve health outcomes.” She added that the partnership extends Carrot’s ongoing work in metabolic-fertility care and reinforces its commitment to delivering measurable results for employers and health plans.
Carrot’s clinical teams, who have been trained to interpret data from ŌURA and Stelo, will translate biometrics into tailored care recommendations. The company says this approach provides members with clearer visibility across their menstrual cycles, sleep patterns, stress levels, physical activity, and glucose trends, enabling more informed and evidence-based decisions.
Members preparing for pregnancy in the Premester phase will receive insights into factors linked to improved outcomes. Carrot users can also work with nutritionists while using Oura’s Meals feature, helping connect diet choices to sleep, activity, and metabolic performance. For those undergoing fertility treatment or tracking conception attempts, Oura Ring data may also help identify fertile windows.
Dr. Chris Curry, M.D., PhD, clinical director, women’s health at ŌURA, said, “Our bodies are constantly sending signals, but most of the time we’re not equipped to understand them or take action on them… having real data about what’s happening inside your body – along with Carrot’s clinical experts providing personalized support – can turn uncertainty into clarity.”
Members participating in Sprints will gain access to Oura Ring devices and Stelos from November 2025, with full data integrations between Carrot, ŌURA and Dexcom expected in early 2026. The companies say this marks the beginning of wider expansion plans to bring wearable-technology support to all life stages covered by Carrot.
